Literature DB >> 18771526

Development of the WHO classification of tumors of the central nervous system: a historical perspective.

Bernd W Scheithauer1.   

Abstract

The classification of brain tumors has undergone numerous changes over the past half century. The World Health Organization has played a key role in the effort. Four versions of its Classification of Tumours of the Central Nervous System have been published. The present work chronicles their progress, placing emphasis on the historical context of the earliest effort.

Entities:  

Mesh:

Year:  2009        PMID: 18771526     DOI: 10.1111/j.1750-3639.2008.00192.x

Source DB:  PubMed          Journal:  Brain Pathol        ISSN: 1015-6305            Impact factor:   6.508


  23 in total

Review 1.  The new World Health Organization Classification of Central Nervous System Tumors: what can the neuroradiologist really say?

Authors:  A G Osborn; K L Salzman; M M Thurnher; J H Rees; M Castillo
Journal:  AJNR Am J Neuroradiol       Date:  2011-08-11       Impact factor: 3.825

2.  Adult glioblastoma multiforme survival in the temozolomide era: a population-based analysis of Surveillance, Epidemiology, and End Results registries.

Authors:  Amy S Darefsky; Joseph T King; Robert Dubrow
Journal:  Cancer       Date:  2011-08-31       Impact factor: 6.860

Review 3.  Evolving Insights into the Molecular Neuropathology of Diffuse Gliomas in Adults.

Authors:  Floris P Barthel; Kevin C Johnson; Pieter Wesseling; Roel G W Verhaak
Journal:  Neurol Clin       Date:  2018-08       Impact factor: 3.806

Review 4.  [Alterations in the WHO classification of brain tumors from 2016].

Authors:  W J Schulz-Schaeffer
Journal:  Radiologe       Date:  2017-09       Impact factor: 0.635

Review 5.  On glioblastoma and the search for a cure: where do we stand?

Authors:  John Bianco; Chiara Bastiancich; Aleksander Jankovski; Anne des Rieux; Véronique Préat; Fabienne Danhier
Journal:  Cell Mol Life Sci       Date:  2017-02-17       Impact factor: 9.261

6.  Embryonal tumor with multilayered rosettes, C19MC-altered (ETMR): a newly defined pediatric brain tumor.

Authors:  Yu-Chun Pei; Guo-Hao Huang; Xiao-Hong Yao; Xiu-Wu Bian; Fei Li; Yan Xiang; Lin Yang; Sheng-Qing Lv; Jun Liu
Journal:  Int J Clin Exp Pathol       Date:  2019-08-01

7.  Childhood cancer incidence trends in association with US folic acid fortification (1986-2008).

Authors:  Amy M Linabery; Kimberly J Johnson; Julie A Ross
Journal:  Pediatrics       Date:  2012-05-21       Impact factor: 7.124

Review 8.  Low-grade ependymoma with late metastasis: autopsy case study and literature review.

Authors:  Wael Alshaya; Vivek Mehta; Beverly A Wilson; Susan Chafe; Keith E Aronyk; Jian-Qiang Lu
Journal:  Childs Nerv Syst       Date:  2015-05-10       Impact factor: 1.475

9.  Pathology concordance levels for meningioma classification and grading in NRG Oncology RTOG Trial 0539.

Authors:  C Leland Rogers; Arie Perry; Stephanie Pugh; Michael A Vogelbaum; David Brachman; William McMillan; Joseph Jenrette; Igor Barani; Dennis Shrieve; Andy Sloan; Joseph Bovi; Young Kwok; Stuart H Burri; Samuel T Chao; Aaron C Spalding; Mitchell S Anscher; Beatrice Bloom; Minesh Mehta
Journal:  Neuro Oncol       Date:  2015-10-22       Impact factor: 12.300

Review 10.  Multifunctional nanoparticles for brain tumor imaging and therapy.

Authors:  Yu Cheng; Ramin A Morshed; Brenda Auffinger; Alex L Tobias; Maciej S Lesniak
Journal:  Adv Drug Deliv Rev       Date:  2013-09-20       Impact factor: 15.470

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.